We are live on
!
Find out more
Alkeon Capital Management Portfolio holdings
AUM
$59.5B
1-Year Est. Return
51.63%
This Fund
S&P 500
This Quarter
Est. Return
-7.63%
1 Year Est. Return
+51.63%
3 Year Est. Return
+162.63%
5 Year Est. Return
+168.42%
10 Year Est. Return
+1,374.92%
AUM
$23.4B
AUM Growth
-$3.42B
(-13%)
Cap. Flow
+$925M
Cap. Flow
% of AUM
3.95%
Top 10 Holdings %
Top 10 Hldgs %
53.34%
Holding
153
New
20
Increased
48
Reduced
14
Closed
17
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$387M |
| 2 |
Microsoft
MSFT
|
+$333M |
| 3 |
RingCentral
RNG
|
+$277M |
| 4 |
Mercado Libre
MELI
|
+$261M |
| 5 |
Amazon
AMZN
|
+$234M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
LK
Luckin Coffee Inc. American Depositary Shares
LK
|
+$158M |
| 2 |
Sea Limited
SE
|
+$68.3M |
| 3 |
Shopify
SHOP
|
+$49.6M |
| 4 |
XLNX
Xilinx Inc
XLNX
|
+$44.4M |
| 5 |
PLAN
Anaplan, Inc.
PLAN
|
+$32.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.58% |
| 2 | Consumer Discretionary | 8.24% |
| 3 | Financials | 4.65% |
| 4 | Communication Services | 4.28% |
| 5 | Industrials | 2.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Elastic
ESTC
$7.95B
| $24.3M | 0.1% |
435,824
+5,824
| +1% | +$376K |
|
|
ALTR
102
DELISTED
Altair Engineering Inc
ALTR
| $24M | 0.1% |
905,000
| – | – |
|
103
TJX Companies
TJX
$175B
| $23.9M | 0.1% |
+500,000
| New | +$28.8M |
|
|
DCPH
104
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $23.5M | 0.1% |
570,975
+148,940
| +35% | +$8.27M |
|
105
Take-Two Interactive
TTWO
$47.4B
| $23.3M | 0.1% |
196,022
-100,000
| -34% | -$11.8M |
|
106
CALL
StoneCo
STNE
$2.53B
| $21.8M | 0.09% |
+1,000,000
| New | +$38.1M |
|
|
APLT
107
DELISTED
Applied Therapeutics
APLT
| $20.9M | 0.09% |
638,039
+198,000
| +45% | +$8.01M |
|
|
TPTX
108
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $20.4M | 0.09% |
457,000
+100,000
| +28% | +$5.31M |
|
|
AKRO
109
DELISTED
Akero Therapeutics
AKRO
| $19.6M | 0.08% |
924,594
+485,000
| +110% | +$10.4M |
|
110
Agios Pharmaceuticals
AGIO
$1.95B
| $17.4M | 0.07% |
491,615
| – | – |
|
111
XP
XP
$8.39B
| $17.4M | 0.07% |
900,000
+500,000
| +125% | +$16.9M |
|
|
TCDA
112
DELISTED
Tricida, Inc. Common Stock
TCDA
| $15.6M | 0.07% |
709,400
| – | – |
|
113
TG Therapeutics
TGTX
$7.55B
| $15.4M | 0.07% |
1,565,000
+565,000
| +57% | +$7.14M |
|
114
Unifirst Corp
UNF
$5.23B
| $9.06M | 0.04% |
60,000
| – | – |
|
115
Beam Therapeutics
BEAM
$2.82B
| $9M | 0.04% |
+500,000
| New | +$10.9M |
|
116
Zoom
ZM
$31.4B
| $8.77M | 0.04% |
60,000
| – | – |
|
117
Passage Bio
PASG
$14.7M
| $7.95M | 0.03% |
+25,250
| New | +$7.9M |
|
118
ServiceNow
NOW
$131B
| $5.73M | 0.02% |
100,000
| – | – |
|
119
Datadog
DDOG
$93.4B
| $5.4M | 0.02% |
150,000
| – | – |
|
120
Dianthus Therapeutics
DNTH
$6.2B
| $3.77M | 0.02% |
37,500
| – | – |
|
121
Cytokinetics
CYTK
$10.5B
| $3.24M | 0.01% |
+275,000
| New | +$3.51M |
|
|
STML
122
DELISTED
Stemline Therapeutics, Inc.
STML
| $3.15M | 0.01% |
650,500
-175,000
| -21% | -$1.13M |
|
123
Neurogene
NGNE
$726M
| $2.28M | 0.01% |
10,000
| – | – |
|
124
Denali Therapeutics
DNLI
$3.98B
| $1.75M | 0.01% |
+100,000
| New | +$2.09M |
|
125
Arcus Biosciences
RCUS
$3.66B
| $1.67M | 0.01% |
+120,000
| New | +$1.49M |
|
Similar funds
QCM
NAMI
Alkeon Capital Management's Q1 2020 Portfolio in Review
As of Q1 2020, Alkeon Capital Management held 153 positions worth $23.4B, down 13% from $26.8B the previous quarter. Its ten largest holdings account for 53% of the portfolio.
Alkeon Capital Management deployed $925M of net new capital in Q1 2020, opening 20 new positions and adding to 48 existing holdings. Its largest new stake was Apple: 5,264,000 shares worth $335M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was Sea Limited, an estimated $68.3M trimmed.
- Alkeon Capital Management's largest Q1 2020 buy was Apple: 5,264,000 shares worth $335M.
- Alkeon Capital Management added most to Microsoft in Q1 2020, an estimated $333M increase.
- Alkeon Capital Management's biggest Q1 2020 reduction was Sea Limited, cutting an estimated $68.3M.
- Alkeon Capital Management fully exited Luckin Coffee Inc. American Depositary Shares in Q1 2020, selling an estimated $158M.
- Alkeon Capital Management's ten largest holdings make up 53% of its $23.4B portfolio in Q1 2020.
- Alkeon Capital Management opened 20 new positions and closed 17 in Q1 2020.
- Alkeon Capital Management's portfolio value fell 13% quarter-over-quarter to $23.4B.
Based on Alkeon Capital Management's 13F filing for Q1 2020, filed 15 May 2020.